https://www.openbell.ai/ 2026-10-28T08:25:22.358Z hourly 1.0 https://www.openbell.ai/support 2026-10-28T08:25:22.358Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-28T08:25:22.358Z monthly 0.5 https://www.openbell.ai/terms 2026-10-28T08:25:22.358Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-28T08:25:22.358Z hourly 0.8 https://www.openbell.ai/news/NEWBRY:1793174616000 2026-10-28T08:03:36.000Z daily 0.9 https://cdn.brandfetch.io/NEWBRY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Newbury Pharmaceuticals Secures Generic Approval for Prukalopride Newbury Pharmaceuticals AB received generic approval for prucalopride, allowing it to move toward commercializing the prescription drug in its target markets. The approval supports the company’s strategy to expand its specialty-treatment portfolio in the Nordic region. The announcement disclosed no financial terms or launch timeline. https://www.openbell.ai/news/BIG:1793174612000 2026-10-28T08:03:32.000Z daily 0.9 https://cdn.brandfetch.io/BIG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bigben Interactive Announces Q2 2026-2027 Sales Results Bigben Interactive reported Q2 2026–2027 sales of €46.4 million for July 1–September 30, 2026, down 12.8% from the prior-year period. Following the October 8 sale of subsidiary Bigben Connected to MODELABS, the group is applying IFRS 5 to consolidated revenue. Nacon’s judicial reorganization observation period has been extended to March 2, 2027, while a recovery plan that includes debt restructuring is being prepared for submission to the Lille Métropole Commercial Court. https://www.openbell.ai/news/IUR:1793174596000 2026-10-28T08:03:16.000Z daily 0.9 https://cdn.brandfetch.io/IUR/w/400/h/400?c=1idopYfmtR7ZKg8QMud KAP AG Adjusts 2026 Financial Guidance KAP AG lowered its 2026 revenue guidance to EUR 220 million–EUR 240 million from EUR 230 million–EUR 250 million, and its normalised EBITDA forecast to EUR 14.5 million–EUR 17.5 million from EUR 19 million–EUR 23 million. The company attributed the revisions to currency headwinds from the stronger Israeli shekel and Hungarian forint, as well as a major EV customer’s short-notice withdrawal of expected call-offs at its Heiche US facility in Jasper, causing significant capacity underutilisation. https://www.openbell.ai/news/GGEO:1793174596000 2026-10-28T08:03:16.000Z daily 0.9 https://cdn.brandfetch.io/GGEO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guideline Geo AB Reports Financial Results for Third Quarter 2026 Guideline Geo AB reported third-quarter 2026 revenue of SEK 42.2 million, down 8.3% from SEK 46.0 million in the same quarter of 2025. Earnings per share fell to SEK 0.16 from SEK 0.26 year over year. https://www.openbell.ai/news/BALCO:1793174592000 2026-10-28T08:03:12.000Z daily 0.9 https://cdn.brandfetch.io/BALCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Balco Group Reports Q3 2026 Financial Results Balco Group AB reported a loss in Q3 2026 following company write-downs, while adjusted EBITA was SEK 1.4 million. The CEO said early signs suggest the company’s strategic measures are beginning to affect performance. https://www.openbell.ai/news/DANT:1793174592000 2026-10-28T08:03:12.000Z daily 0.9 https://cdn.brandfetch.io/DANT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Dantax A/S Reports Q1 2026/27 Financial Results Dantax A/S reported a loss before tax of DKK 2.2 million and a loss after tax of DKK 1.7 million for Q1 of fiscal 2026/27, compared with profits of DKK 2.5 million and DKK 2.0 million, respectively, a year earlier. Operating profit before tax was DKK 399,000, while financial items generated a DKK 2.6 million loss before tax. The company also reported an average investment of DKK 28.5 million in shares during the quarter. https://www.openbell.ai/news/PROXI:1793174587000 2026-10-28T08:03:07.000Z daily 0.9 https://cdn.brandfetch.io/PROXI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Proximar Seafood Expects to Run Out of Cash by October-end, Misses Interest Payment Deadline Proximar Seafood AS said it expects to exhaust its cash reserves by the end of October 2026 and has missed a scheduled interest payment deadline. The land-based salmon farmer, which operates production facilities in Japan, said its liquidity crisis poses a material risk to ongoing operations and its capital structure. https://www.openbell.ai/news/ONTEX:1793174559000 2026-10-28T08:02:39.000Z daily 0.9 https://cdn.brandfetch.io/ONTEX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ontex Group NV Reports Q3 2026 Results and Revises Full-Year Outlook Ontex Group NV lowered its 2026 adjusted EBITDA outlook to €143 million–€148 million from €165 million–€180 million, citing elevated and volatile costs, slower pricing increases, and lower sales volumes. Its “Focus to Value” transformation program generated €45 million in savings year to date. The company’s leverage ratio reached 3.75x at the end of September, and it now expects full-year free cash flow of negative €10 million to zero. https://www.openbell.ai/news/ADVE:1793174558000 2026-10-28T08:02:38.000Z daily 0.9 https://cdn.brandfetch.io/ADVE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Advenica Reports Q3 2026 Financial Commentary Advenica AB reported higher revenue in the third quarter of 2026, attributing the increase to growing demand for its cybersecurity solutions in industrial and critical infrastructure sectors. The company provided the commentary on October 27, 2026, but the report did not specify revenue, profit, growth percentages, or stock-price movements. https://www.openbell.ai/news/CDZ0:1793174550000 2026-10-28T08:02:30.000Z daily 0.9 https://cdn.brandfetch.io/CDZ0/w/400/h/400?c=1idopYfmtR7ZKg8QMud MHP Hotel AG Reports Strong Q3 2026 Financial Results MHP Hotel AG reported record third-quarter 2026 hotel revenue of €56.6 million, up 25.1% year over year. Revenue for the first nine months rose about 25% to €154.9 million, supported by its existing portfolio and the consolidation of Hyatt Regency Vienna and revenue from Conrad Hamburg. Average daily rate reached €233, the company retained its TREUGAST ‘AA’ rating, and management confirmed its full-year 2026 financial outlook. https://www.openbell.ai/news/UBK:1793174549000 2026-10-28T08:02:29.000Z daily 0.9 https://cdn.brandfetch.io/UBK/w/400/h/400?c=1idopYfmtR7ZKg8QMud UmweltBank Reports Improved Profitability and Strong New Lending in Q3 2026 UmweltBank AG reported improved profitability in the third quarter of 2026 and strong growth in new lending. The update did not provide specific financial figures or report stock-price movements. https://www.openbell.ai/news/TTK:1793174528000 2026-10-28T08:02:08.000Z daily 0.9 https://cdn.brandfetch.io/TTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud TAKKT AG Reports Q3 2026 Financial Results TAKKT AG reported that its business stabilized in Q3 2026, with organic sales down 4.3%, close to the prior quarter’s decline. Sales for the first nine months totaled EUR 685.6 million, a 5.1% organic decrease. The company said its TAKKT Forward initiative is progressing, while a cyberattack is affecting operations; Industrial & Packaging remained stable and U.S. demand improved in Office Furniture & Displays. https://www.openbell.ai/news/BRG:1793174524000 2026-10-28T08:02:04.000Z daily 0.9 https://cdn.brandfetch.io/BRG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Borregaard Reports All-Time High EBITDA for Q3 2026 Borregaard reported record third-quarter 2026 EBITDA of NOK 557 million, up from NOK 440 million a year earlier, while operating revenue increased to NOK 1,894 million from NOK 1,799 million. Profit before tax was NOK 394 million and earnings per share was NOK 2.96. The company attributed the improvement to strong performance at its Sarpsborg biorefinery, cost savings, energy optimization and selective price increases, with all three business segments contributing. https://www.openbell.ai/news/PAL:1793174520000 2026-10-28T08:02:00.000Z daily 0.9 https://cdn.brandfetch.io/PAL/w/400/h/400?c=1idopYfmtR7ZKg8QMud PALFINGER Reports Q1-Q3 2026 Results and Strategic Portfolio Adjustments Palfinger AG reported revenue of EUR 1,616.7 million and EBIT of EUR 120.7 million for the first three quarters of 2026. It is expanding its efficiency program to target EUR 50 million in savings by 2028 amid weak conditions in Germany and investment hesitation in the U.S., and has agreed to sell its Tail & Passenger Lift business. A non-cash impairment of about EUR 135 million on Russian assets reduced the consolidated net result but did not affect EBIT or cash flow. For full-year 2026, management expects revenue to be slightly higher and EBIT slightly lower than the previous year. https://www.openbell.ai/news/IG:1793174512000 2026-10-28T08:01:52.000Z daily 0.9 https://cdn.brandfetch.io/IG/w/400/h/400?c=1idopYfmtR7ZKg8QMud InstallatørGruppen A/S Reports Q3 2026 Financial Results InstallatørGruppen A/S reported Q3 2026 revenue of DKK 1,235 million, up 42.8% year over year, with organic growth of 15.2% driven by new orders and delayed projects moving forward. Adjusted EBITA was DKK 104 million, representing an 8.4% margin, which the company said reflected a shift toward project-based business. Its order book reached DKK 4.6 billion, and it completed nine acquisitions in the first nine months of 2026. https://www.openbell.ai/news/IDIA:1793174511000 2026-10-28T08:01:51.000Z daily 0.9 https://cdn.brandfetch.io/IDIA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Idorsia Initiates Phase 3 FAB-KLEAR Study and Enters Co-Development Agreement with Nxera Idorsia initiated FAB-KLEAR, a pivotal Phase 3 kidney biopsy study evaluating lucerastat as a potential disease-modifying treatment for adults with Fabry disease. The company also signed a co-development and commercialization agreement granting Nxera exclusive rights to develop and commercialize lucerastat in Japan and selected Asia Pacific territories, excluding China. Nxera will pay Idorsia CHF 7 million upfront, contribute to the global Phase 3 program, and Idorsia is eligible for royalties on sales in the licensed territories. https://www.openbell.ai/news/BNOR:1793174511000 2026-10-28T08:01:51.000Z daily 0.9 https://cdn.brandfetch.io/BNOR/w/400/h/400?c=1idopYfmtR7ZKg8QMud BlueNord ASA Announces Third Quarter 2026 Financial Results BlueNord ASA reported third-quarter 2026 revenue of USD 346 million and EBITDA of USD 219.6 million. Net hydrocarbon production was 43.6 mboepd, with the Tyra hub reaching approximately 30 mboepd after maintenance. Available liquidity totaled USD 392.8 million, comprising USD 131.3 million in cash and USD 261 million in undrawn RBL capacity. The proposed statutory merger with Vår Energi ASA, previously approved by shareholders, remains in progress. https://www.openbell.ai/news/CRBN:1793174510000 2026-10-28T08:01:50.000Z daily 0.9 https://cdn.brandfetch.io/CRBN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Corbion Reports Strong Q3 2026 Results Corbion reported strong volume-led sales growth and significant margin improvements in the third quarter and first nine months of 2026. Management reaffirmed its full-year guidance. The report did not provide specific revenue or profit figures or mention a stock-price impact. https://www.openbell.ai/news/ASY:1793174505000 2026-10-28T08:01:45.000Z daily 0.9 https://cdn.brandfetch.io/ASY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Assystem Reports First-Half 2026 Results and Nine-Month Revenue Assystem reported first-nine-month 2026 revenue of €492.1 million, up 2.8% organically. First-half EBITA was €21.1 million, with a 6.4% margin. Nuclear activities grew 7.7% organically and France grew 4.5%. The company updated its 2026 targets to approximately 3% organic revenue growth and an EBITA margin of around 7%. https://www.openbell.ai/news/HYQ:1793174505000 2026-10-28T08:01:45.000Z daily 0.9 https://cdn.brandfetch.io/HYQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hypoport Reports Financial Results for Third Quarter 2026 Hypoport SE reported third-quarter 2026 EBIT of €10.8 million, up from €7.6 million a year earlier, while gross profit rose to €70 million from €67 million. For the first nine months, EBIT increased 27.5% to €30.1 million from €23.6 million. Europace platform activity grew 1% in the third quarter, but transaction volume for the first nine months remained stagnant. https://www.openbell.ai/news/STAN:1793174493000 2026-10-28T08:01:33.000Z daily 0.9 https://cdn.brandfetch.io/STAN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Standard Chartered Reports Strong Third Quarter 2026 Results and Raises Guidance Standard Chartered reported third-quarter 2026 operating income up 14% year over year to $5.8 billion and profit before tax up 29% to $2.3 billion. Return on Tangible Equity was 15.7%, while earnings per share rose 55% to 68.9 cents and credit impairment costs fell by half to $90 million. Growth in Wealth Solutions and Global Markets supported the results, and the bank raised its 2026 income guidance while targeting full-year RoTE of approximately 14%. Its Common Equity Tier 1 ratio was 13.8%; the article did not report a share-price move. https://www.openbell.ai/news/AKSO:1793174493000 2026-10-28T08:01:33.000Z daily 0.9 https://cdn.brandfetch.io/AKSO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Aker Solutions Reports Third-Quarter 2026 Financial Results Aker Solutions reported third-quarter 2026 revenue of NOK 13.5 billion and an EBITDA margin of 9.6%, or 7.7% excluding SLB OneSubsea. It reaffirmed 2026 guidance of NOK 53–55 billion in revenue and a 7.5–8.0% EBITDA margin excluding SLB OneSubsea, while forecasting 2027 revenue of NOK 35–40 billion and a 7.0–8.0% margin. The company ended the quarter with NOK 5.8 billion in net cash and reported the sail-away of Aker BP’s Valhall PWP and Hugin B topside platforms. https://www.openbell.ai/news/GSK:1793172699000 2026-10-28T07:31:39.000Z daily 0.9 https://cdn.brandfetch.io/GSK/w/400/h/400?c=1idopYfmtR7ZKg8QMud GSK Reports Strong Third Quarter 2026 Financial Results GSK reported third-quarter 2026 sales of £8.9 billion, up 5% at constant exchange rates, and core EPS of 54.6 pence, above the 50.4-pence analyst consensus. Specialty Medicines led growth, with sales up 15%, including increases of 10% in HIV products and 23% in oncology. GSK reaffirmed its 2026 guidance, expecting turnover growth in the upper half of its 3%–5% range and core EPS growth in the lower half of its 7%–9% range, both at constant exchange rates. The company also cited regulatory approvals and new Phase III trials in its R&D pipeline, alongside a £328 million charge for its ongoing savings program. https://www.openbell.ai/news/BIRG:1793172693000 2026-10-28T07:31:33.000Z daily 0.9 https://cdn.brandfetch.io/BIRG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bank of Ireland Group Reports Q3 2026 Interim Management Statement Bank of Ireland Group reported a 6% increase in total income for the nine months ended September 30, 2026, driven by 4% growth in net interest income and 6% growth in total fee income. Net loans increased by €3.6 billion. The group said its new strategic cycle is supporting income growth and capital generation, and it remains on track for a strong full-year 2026 performance and to meet its 2028 financial targets. https://www.openbell.ai/news/UL:1793172691000 2026-10-28T07:31:31.000Z daily 0.9 https://cdn.brandfetch.io/UL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Unilever Reports Q3 2026 Results and Raises Outlook Unilever reported third-quarter 2026 revenue of EUR 13.27 billion, with price growth of 2.3% and volume growth of 2.9%. Following the results, management raised the company’s financial outlook. https://www.openbell.ai/news/KEFI:1793170917000 2026-10-28T07:01:57.000Z daily 0.9 https://cdn.brandfetch.io/KEFI/w/400/h/400?c=1idopYfmtR7ZKg8QMud KEFI Gold and Copper Announces Conditional Approval for Jibal Qutman Gold Project Development KEFI Gold and Copper said its joint venture, Gold and Minerals Company Limited, received conditional approval for Stage 1 development of Saudi Arabia’s Jibal Qutman Gold Project, subject to the final granting of a mining license. The project targets a fourth-quarter 2026 start and an estimated US$87 million capital program, with projected recovery of about 258,000 ounces of gold over seven years and a post-tax net present value of US$141 million to US$275 million. KEFI holds a 13% stake and expects to contribute US$10 million to US$12 million over 24 months; the company described the approval as a milestone toward its first producing operation in Saudi Arabia. https://www.openbell.ai/news/SANOMA:1793170885000 2026-10-28T07:01:25.000Z daily 0.9 https://cdn.brandfetch.io/SANOMA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Sanoma Corporation Interim Report 1 January–30 September 2026 Sanoma Corporation’s interim report for 1 January–30 September 2026 reported strong growth in adjusted operating profit. The report covers the company’s financial performance and operations through the end of the third quarter; no specific financial figures or stock-market movements were provided. https://www.openbell.ai/news/CAH:1793152919000 2026-10-28T02:01:59.000Z daily 0.9 https://cdn.brandfetch.io/CAH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Pentagon Awards Cardinal Health $1.5 Billion Contract Cardinal Health won a $1.5 billion fixed-price, indefinite-delivery/indefinite-quantity contract under the U.S. Department of Defense’s Medical Surgical Prime Vendor program. The award followed a competitive process with eight submissions and includes a two-year, six-month base period plus three optional periods of the same length. The ordering period is scheduled to end December 6, 2029, with oversight by the Defense Logistics Agency Troop Support in Philadelphia.